Order byBest matchMost fresh

Hims, Eli Lilly and weight loss

Digest more
Top News
Impacts
Lilly said Strive's tirzepatide products, which come in standard doses added with vitamin B12 or glycine, are falsely suggested to be safer and more effective than FDA-approved medicines.
From Reuters
Hims & Hers expects at least $725 million in revenue from its weight-loss services alone in 2025.
From U.S. News & World Report

Read more on News Digest

Lilly sues two compounders over copies of weight-loss drugs
Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ingredient in its popular weight-loss and diabetes medicines.
Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs
Key Takeaways Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.The treatments will each cost $1,
Eli Lilly weight loss therapy added to Hims & Hers platform
Shares of Hims & Hers Health (NYSE:HIMS) traded higher on Tuesday after the telehealth company announced the addition of branded versions of Eli Lilly’s (NYSE:LLY) popular weight loss therapy tirzepatide for sale on its platform.
Zepbound Now Available Through Hims & Hers
Zepbound is made by drugmaker Eli Lilly. While Hims & Hers offers it for $1,899 per month, Lilly said the price on its own LillyDirect platform starts at $349 for self-paying customers. With insurance,
Why April Could Be a Huge Month for Eli Lilly Stock
A key drug that investors are going to be following this year is orforglipron, a once-daily pill that Eli Lilly is developing for weight loss and other indications. The early data has been encouraging,
Why Hims & Hers Health Stock Soared Tuesday
Hims & Hers revealed Tuesday that it will begin offering branded versions of Eli Lilly's tirzepatide -- the active ingredient in weight loss
Senate Republican questions FDA chief on counterfeit weight loss drugs
Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he says are being included online weight loss drugs. In a letter to
New Atlas7d
Next-gen weight-loss drugs will be here within 12 months
Less than five years on from when Novo Nordisk's semaglutide drug received FDA approval for weight loss (Wegovy), the Danish pharmaceutical company has announced it will seek regulatory approval ...
Costly GLP-1 drug use for weight loss has soared, study reports
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.
Eli Lilly sues Strive and Empower as FDA lifts tirzepatide shortage status
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
Popular weight-loss drug Wegovy receives approval in New Zealand
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”. Wegovy is a semaglutide prescription injection developed by Danish healthcare company Novo Nordisk Pharmaceuticals.
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The restrictions began because the FDA declared a shortage of tirzepatide, often sold as Zepbound, and semaglutide, often sold as Wegovy, over.
JD Supra8d
FDA Update: Current Guidelines for Semaglutide and Tirzepatide Compounding
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP-1 medications
How to Get Weight Loss Meds Without Insurance
Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden popularity of medications like Ozempic® — a diabetes drug that had major shortages when doctors discovered that it could be used as an effective obesity medicine and weight loss tool.
Page Six10d
Amy Schumer back on weight loss drugs after ‘horrible experience’ with Wegovy
Amy Schumer revealed she’s on a new weight loss medication ... While both drugs are used to help with weight loss, Mounjaro has been FDA-approved to treat Type II Diabetes, while Wegovy has ...
Feedback